Physician profile
Jose Diaz
NPI 1689085714
$1,156.13
in general payments reported to CMS, 2019-2025
14 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Women'S Health Care, Ambulatory provider received nationally (typical 2025 total: $102).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $612 · 2022: $199 · 2023: $150 · 2024: $21.42 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $371.16 | 2021-2023 | Nplate, Xgeva, Vectibix |
| Astellas Pharma US INC | $217.11 | 2021 | |
| Abbvie INC. | $198.13 | 2022-2025 | |
| Blueprint Medicines Corporation | $49.89 | 2022 | |
| Genzyme Corporation | $43.20 | 2021 | |
| Novo Nordisk INC | $40.13 | 2021-2023 | Novoeight, Novoseven |
| Tolmar, INC. | $37.24 | 2023 | |
| Merck Sharp & Dohme LLC | $33.16 | 2025 | Lynparza, Keytruda |
| Octapharma USA, INC. | $33.00 | 2021 | |
| Janssen Biotech, INC. | $32.31 | 2023 | |
| Emd Serono, INC. | $31.21 | 2022 | |
| Puma Biotechnology, INC. | $27.26 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $21.99 | 2025 | Tagrisso |
| Pfizer INC. | $20.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.